SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rubio, M.
Right arrow Articles by Schwartz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubio, M.
Right arrow Articles by Schwartz, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Sarcoplasmic Reticulum Adenosine Triphosphatase Overexpression in the L-type Ca2+ Channel Mouse Results in Cardiomyopathy and Ca2+-Induced Arrhythmogenesis

Marta Rubio, PhD

Institute of Molecular Pharmacology and Biophysics, University of Cincinnati Medical Center, Cincinnati

Ilona Bodi, PhD

Institute of Molecular Pharmacology and Biophysics, University of Cincinnati Medical Center, Cincinnati

Geraldine A. Fuller-Bicer, DVM, PhD

Institute of Molecular Pharmacology and Biophysics, University of Cincinnati Medical Center, Cincinnati

Harvey S. Hahn, MD

Department of Internal Medicine, Division of Cardiology, University of Cincinnati Medical Center, Cincinnati

Muthu Periasamy, PhD

Department of Physiology and Cell Biology, College of Medicine and Public Health, The Ohio State University, Columbus, OH

Arnold Schwartz, PhD

Institute of Molecular Pharmacology and Biophysics, University of Cincinnati Medical Center, Cincinnati

Background: Overexpression of the L-type voltage-dependent calcium channel {alpha}1C-subunit (L-VDCC OE) in transgenic mice results in adaptive hypertrophy followed by a maladaptive phase associated with a decrease in sarcoplasmic reticulum adenosine triphosphatase (SERCA)2a expression at 8 to 10 months of age. Overexpressing SERCA to manipulate calcium (Ca2+) cycling and prevent pathologic phenotypes in some models of heart failure has been proven to be a promising genetic strategy.

Objective: In this study we investigated whether genetic manipulation that increases Ca2+ uptake into the sarcoplasmic reticulum by overexpressing SERCA1a (skeletal muscle specific) into the L-VDCC OE background could restore or further deteriorate Ca2+ cycling, contractile dysfunction, and electrical remodeling in the heart failure phenotype.

Results: We found that the survival rate of L-VDCC OE/SERCA1a OE double transgenic mice decreased by 50%. L-VDCC OE/SERCA1a OE mice displayed an accelerated phenotype of severe dilation of both ventricles associated with deteriorated left ventricular function. Voltage clamp experiments revealed enhanced increased inward Ca2+ current density and decreased the transient outward potassium current. Action potential duration in double transgenic ventricular myocytes was prolonged, and isoproterenol induced early afterdepolarization. These mice demonstrated a high incidence of spontaneous left ventricular arrhythmia. Expression of the proarrhythmic signaling protein Ca2+/calmodulin-dependent kinase II (CaMKII) was increased while connexin43 expression was decreased, defining an important putative mechanism in the electrophysiologic disturbances and mortality.

Conclusions: Despite previous reports of improved cardiac function in heart failure models after SERCA intervention, our results advocate the need to elucidate the involvement of augmented Ca2+ cycling in arrhythmogenesis.

Key Words: L-type voltage-dependent calcium channel • sarcoplasmic reticulum adenosinetriphosphatase • augmented Ca2+ cycling

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 10, No. 4, 235-249 (2005)
DOI: 10.1177/107424840501000404


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi
Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. E. Anderson
Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus
Cardiovasc Res, March 1, 2007; 73(4): 657 - 666.
[Abstract] [Full Text] [PDF]



Advertisement